Clinical trial NCT05915338: Training on Using ıInsulin in Patients With Type 2 Diabetes
Official title: The Eof ıInsulin Use Education on Safe Drug Administration, Pain Level and Perception of Treatment in Patients With Type 2 Diabetes
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Insulin Dependent Diabetes
Diabetes type2
Keywords: Tip 2 Diyabet
Güvenli İlaç Kullanımı
Tedavi Algısı
İnsülin
Lead sponsor: Inonu University
Sponsor class: OTHER
First posted: 2023-06-23
Enrollment: 84
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: OTHER
Time perspective: OTHER
Sampling method: PROBABILITY_SAMPLE
Study population: Patients with Type 2 Diabetes

Brief summary: This study was conducted to evaluate the effect of individual insulin use training given to patients with type 2 diabetes using insulin on safe drug administration, pain level and perception of treatment. The study was conducted between October 2022 and March 2023 with a randomized control group.

Detailed description: Objective: The aim of this study was to examine the effects of individual insulin use training given to patients with Type 2 diabetes on safe drug administration, pain level and treatment perception, and to contribute to both national and international literature.

Method: It was conducted between October 2022 and March 2023 as a randomized controlled study in a pre-test-post-test order to determine the effect of individual insulin use education given to patients with type 2 diabetes on safe drug administration, pain level and treatment perception. The data were collected by the researchers with the descriptive information form of the patients, the Insulin Administration Skill Observation Form, the Visual Analogue Scale and the Insulin Therapy Evaluation Scale.

Data Collection: Face-to-face and individual interviews with patients who applied to the Internal Diseases and Endocrinology Polyclinic and Diabetes Nursing Polyclinics of a state hospital in a city located in the Southeastern Anatolia Region of Turkey, and who were hospitalized in the Internal Diseases, Endocrinology, Physical Therapy and Rehabilitation and Cardiology Services. collected using the method. A pilot study was not conducted before starting the study. Before the study, all patients were informed about the study and their verbal and written consents were obtained.

Eligibility criteria: Inclusion Criteria:

Patients included in the study;

* 18 years and over Using insulin injections for at least six months or longer
* Meeting the American Diabetes Association (ADA, 2021) diagnostic criteria for Type 2 diabetes
* No communication and mental problems
* Insulin injection made by himself or his family The patients who agreed to participate in the study.

Exclusion Criteria:

Patients excluded from the study;

* Self or family member health personnel Those with advanced retinopathy, nephropathy, neuropathy
* Diagnosed with type 1 diabetes
* Pregnant or breastfeeding women
* Patients who participated in another clinical trial concurrently or within 1 month prior to the start of the trial.

Primary outcomes:
measure: Fırst follow - up survey
timeFrame: Fırst test-fırst applıcatıon both groups at the begınnıng of the research
Secondary outcomes:
measure: Last test survey
timeFrame: 2 weeks after the fırst watch
Other outcomes:
measure: Durabılıty test for both groups
timeFrame: After 8 weeks, the follow-up test was done to both groups
Locations:
city: Şirnak
country: Turkey
facility: Şirnak Devlet Hastanesi
state: Merkez
Study officials:
References: